AbelZeta
bd_a19285991b4ce96c · schema v1 · pii pii-v1
Full breach record for AbelZeta →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group Spacebears on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
AbelZeta Pharma is a global cell therapy leader focused on discovering, developing and manufacturing therapeutics to address unmet medical needs across hematologic malignancies, inflammatory and immunological diseases and solid tumors.Partners: AstraZeneca, Janssen (J&J), NovartisInvestors: HSG, Yunfeng Capital, GIC, TF Capital, CICC Capital, Sailing Capital, Dangdai Group, AstraZeneca-CICC Fund170,000+ different files670+ separate archives with experiments on various candidates All studies: CAR032, CAR39, CAR66, CAR168, TIL, CD, Tcell, etc. There are a huge number of files and studies, all of which are confidential and valuable for competitive research. https://www.abelzeta.com/
Source provenance
- Source URL
- https://www.ransomware.live/id/QWJlbFpldGFAc3BhY2ViZWFycw==
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Mar 10, 2026
- Raw hash
- 5e6350117a306c6137147d4d1fe9f8c8e28e310769654ae37f5e919e329888e6
Reporting entity
- Name
- spacebears
Victim entity
- Name
- AbelZetanorm: abelzeta
- Domain
- abelzeta.com
- Industry
- Healthcarellm
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· spacebears
- Threat actor
- SpacebearsExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.